Screener
Sutro Biopharma STRO Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $13.63M.
The source filing: Sutro Biopharma’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224170
FAQ
- What is Sutro Biopharma's total debt?
- Sutro Biopharma (STRO) reported total debt of $13.63M in Q1 2026.
- How has Sutro Biopharma's total debt changed year-over-year?
- Sutro Biopharma's total debt decreased by 36.3% year-over-year, from $21.4M to $13.63M.
- What is the long-term trend for Sutro Biopharma's total debt?
- Over 5 years (2020 to 2025), Sutro Biopharma's total debt has grown at a -22.3% compound annual growth rate (CAGR), from $55.25M to $15.67M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Sutro Biopharma's total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude